Fennec Pharma
FENC9.4704.44% ( -0.440 )
About
Fennec Pharma
FENC.US
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Profile
- Company Name
- Fennec Pharmaceuticals Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.fennecpharma.com